Latest

Latest pulmonary disease News | Page 2

  • Latest pulmonary disease news stories and updates. What is happening today? All recent pulmonary disease news and developments. Live coverage and timeline of pulmonary disease. All you need to know about pulmonary disease.
Innovative digital platform to diagnose and treat breathlessness receives $1.87m grant
NIH funds antibiotic trial for HIV and emphysema
Burden of ill health increases in Australia
Researchers discover why viral infections are worse for people with COPD
PT027 recommended by FDA advisory committee as new rescue treatment for asthma
Update on MESSINA Phase III trial for Fasenra in eosinophilic esophagitis
North Queensland pilot program to deliver more effective primary health care
Voice screening App delivers rapid results for Parkinson’s and severe COVID
Tezspire approved in Japan for treatment of severe asthma
UQ startup acquired by Pfizer
Tezspire approved in EU for treatment of severe asthma
World first online singing trial for people with chronic lung disease
Dimerix confirms CLARITY 2.0 Covid study concludes recruitment
MinterEllison advises on Medical Developments’ capital raising
DImerix announces new patient family for DMX-700
Can you get sick from being cold?
Recruitment open for new study of lung disease
New options for health, environmental monitoring with water-resistant gas sensor
Virtual lung therapy by smartphone app rivals traditional method
Tezspire recommended for approval in EU by CHMP for treatment of severe asthma
Australia’s first national biotechnology incubator announces round one funding
Monash projects backed by Australia’s national biotech incubator
Dimerix updates with new and positive DMX-700 data
New drug target identified for inflammatory lung disease
COPD patients respond equally well to Covid vaccine
Tips to cope with Saharan dust
New projects announced for National Drug Discovery Centre
Sleep relief for lung disease
World-first study reveals why people with COPD are more susceptible to Covid
Cochrane Review highlights need for new interventions to improve chronic obstructive pulmonary disease
$10 million investment fuels promising treatments for inflammatory lung disease
Researcher founding scientist of new biotech company launched with AUD$10m investment
Dimerix receives R&D tax rebate for last financial year
Pharmac deal good news for New Zealanders
Update on US regulatory review of Fasenra in chronic rhinosinusitis with nasal polyps
Life-saving medicines unaffordable as PBS co-pay heads to $50 script
Why inflammation is important
ATAGI recommendations on use of Spikevax Covid vaccine in children aged 6 to 11 years
AstraZeneca progresses Ambition Zero Carbon programme with Honeywell partnership to develop next-generation respiratory inhalers
Premature birth linked to lung disease later in life
Saphnelo approved in EU for treatment of moderate to severe systemic lupus erythematosus
RACGP: Queensland pharmacy prescribing trial risks patient safety
Altered gene expression and cell interactions involved in COPD
Transfer of global rights for Eklira and Duaklir to Covis Pharma completed
Saphnelo recommended for approval in EU by CHMP for treatment of patients with systemic lupus erythematosus
Black summer bushfires of 2019-20 led to huge health burden in NSW, study finds
Tezspire approved in US for severe asthma
During summer, hazardous mould species more abundant in rooms with windows

© 2024 - The National Tribune Australia